HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,543,471 | +178.2% | 40,405 | +162.6% | 0.19% | +167.1% |
| Q2 2023 | $554,901 | -79.0% | 15,384 | -77.8% | 0.07% | -76.7% |
| Q1 2023 | $2,646,300 | +24.1% | 69,293 | +84.9% | 0.30% | +23.5% |
| Q4 2022 | $2,132,953 | +341.6% | 37,486 | +209.5% | 0.24% | +367.3% |
| Q1 2022 | $483,000 | -86.9% | 12,113 | -86.6% | 0.05% | -81.6% |
| Q3 2021 | $3,690,000 | +344.6% | 90,705 | +355.6% | 0.28% | +293.1% |
| Q1 2021 | $830,000 | -22.0% | 19,907 | -50.8% | 0.07% | +5.9% |
| Q3 2020 | $1,064,000 | +20.0% | 40,490 | +22.4% | 0.07% | -16.0% |
| Q2 2020 | $887,000 | +124.0% | 33,078 | +48.1% | 0.08% | +237.5% |
| Q4 2019 | $396,000 | – | 22,335 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |